Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
-
EU parliament greenlights digital euro
-
French yachtswoman set to break new barriers in Route du Rhum
-
Two thirds of EU faced harmful ozone levels during heatwave: report
-
Markets steady tracking US-Iran flare-up
-
Russia to take on World Athletics at CAS over ban
-
Italy expels two Russian diplomats accused of spying: minister
-
600 dead in DR Congo Ebola outbreak
-
German exports rise despite Iran war headwinds
-
'Total Eclipse' singer Bonnie Tyler, queen of the 80s power ballad, dies at 75
-
Thousands attend funeral for Afghan cricketer Shapoor Zadran
-
Myanmar names Norwegian Andersen as head of national team
-
Crude pares steep gains as traders take stock after US-Iran flare-up
-
Russell back as Scotland tackle world champions South Africa
-
Cleanup underway as death toll from China floods hits 39
-
Tour de France yellow jersey protocol: 90 minutes of 'stress'
-
Italy recall Allan, Lynagh for All Blacks Nations Championship Test
-
Crude stabilises after US-Iran flare-up rocked peace hopes
-
Rookie fly-half Meredith thrown in for Wallabies debut against France
-
Playmaker Jalibert moves to fullback as France swing axe for Australia clash
-
Taiwan warns of 'destructive' winds as typhoon nears
-
Australian sprint star Gout out of U20 worlds with hamstring tear
-
Farrell rings changes for Ireland's Japan clash
-
Unions to protest as Volkswagen thrashes out job cut plans
-
Magyar's blitz against Orban's Hungary 'mafia' gathers pace
-
Teeth bared in Greece's bear-human showdown
-
Labour leadership contest takes Burnham closer to UK PM's office
-
Alpacas, mini pigs on the loose after floods hit south China zoo
-
New Zealand may join Australia-Fiji defence pact: PM Luxon
-
All Blacks make five changes for Italy Nations Championship clash
-
Fly-half Meredith to make Australia debut against France
-
Western Europe records its hottest June as heatwaves surge: EU monitor
-
US, Iran trade new strikes in fight over Hormuz strait
-
Fashion's mystery man Margiela sells off his archives
-
Modi eyes 'historic' chance to secure Australian uranium
-
Nuclear test-scarred Marshall Islands criticises China missile
-
US crackdown on top AI fuels open-source surge
-
Chip titan SK hynix to set price for mega US listing
-
EU moves closer to kicking kids off social media
-
Crude extends rally as US-Iran flare-up rocks peace hopes
-
Protecting the protectors: racing to save Philippine mangroves
-
Democrat accused of rape exits key US Senate race
-
Expanded World Cup; same old story as Europe dominates quarter-finals
-
Japan student Ito keeps place against Ireland as Jones returns
-
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
-
Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs
-
XCF Global Begins Producing Renewable Fuels at New Rise Renewables Reno
-
DISC Plus Profiles: Why More HR Teams Use Behavioral and DISC Assessments to Reduce Costly Hiring Mistakes
-
Sky Quarry Appoints Refining Industry Veteran Ray Hansen as President of Foreland Refining Corporation
-
ATHA Energy Reports Widest Intersection to Date at Rib North Discovery with 37 m of Composite Uranium Mineralization in Ribn-DD-003 – Multiple Drillholes Demonstrating Continuity of Uranium Mineralization
-
Jaguar Mining Reports Commencement of Directional Drilling Program at Pilar Gold Mine, Minas Gerais, Brazil
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
R.Lee--AT
